Melanotan 1
MT-1, Afamelanotide, Scenesse
Mechanism
Selective MC1R agonist. Stimulates melanocytes to produce eumelanin (brown/black pigment). FDA-approved for EPP (erythropoietic protoporphyria).
Benefits
- ✓UV-independent tanning
- ✓Photoprotection
- ✓Approved for EPP
- ✓Minimal systemic effects vs MT-2
Dosing
250–500mcg daily or every other day. Start low (250mcg) to assess response.
Reconstitution
10mg + 2mL BAC = 5,000mcg/mL.
Cycle Length
Loading phase 2–4 weeks until desired color, then maintenance 1–2x/week.
Timing
SubQ evening (nausea less noticeable during sleep).
Stacks Well With
N/A — typically used alone
Cautions
Causes darkening of existing moles — monitor for changes. Nausea during loading. Avoid if high-risk for melanoma.